Drugs & Healthcare
The LUVEN screening test method detects cancer at its early stages with the accuracy of up to 96%.
- already completed 90% of the project.
Token holders have two opportunities:
- receiving a part of the company income
- exchanging their tokens for testing services with a 30% discount, using or selling them to wholesale customers
Ethereum ERC20 standard token.
|Pre-sale start date||11 Dec 2017|
|Pre-sale end date||28 Dec 2017|
|ICO start date||14 Jan 2018|
|ICO end date||27 Feb 2018|
|Additional Token Emission||No|
At the preICO stage - 3 000 000 tokens (1st day bonus – 30%, 1st week bonus – 25%, 2nd week bonus – 20%, 3d week bonus – 15%)
At the ICO stage - 27 000 000 (1st week – 10%, 1 to 1 onwards)
Referral program 5% purchased by referral
Clinical trials 40%
Legal part 10%
Team remuneration 7%
Bounty campaign 3%
Type of scores
Rating Review and Analytics
|Start ICO||14 Jan 2018|
|End ICO||27 Feb 2018|
|Price||1 LVN = 1 USD|
|MVP||Ready-to-use full version|
Click vote if you want this project to be Post-ICO Rated.
The vote has been noted.